Yatsen Holding Ltd YSG

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NYSE

Last close
Market cap
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-0.01

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $614.6M$464.9M$481.0M$537.3M$916.4M$802.0M
Cost of revenue $134.0M$106.3M$127.0M$172.2M$304.6M$286.5M
Gross profit $480.7M$358.6M$354.0M$365.2M$611.8M$515.6M
R&D $19.6M$15.0M$15.7M$18.4M$22.3M$10.2M
SG&A $43.4M$60.9M$70.6M$104.4M$147.7M$328.4M
Total operating expenses $507.2M$471.6M$482.6M$499.9M$866.7M$926.7M
Operating income -$26.6M-$113.0M-$128.6M-$134.7M-$254.9M-$411.1M
Interest expense $5.8M$11.8M$12.5M$5.0M$7.2M$2.2M
Pre-tax income -$13.2M-$97.7M-$106.1M-$118.7M-$242.9M-$410.9M
Income tax $15.0K$423.0K$452.0K$392.0K$145.0K$1.1M
Net income -$11.6M-$97.0M-$747.8M-$118.2M-$241.8M-$411.9M
EPS, basic -0.01-0.05-0.05-0.05-0.10-0.73
EPS, diluted -0.01-0.05-0.05-0.05-0.10-0.73
Shares, diluted (wtd. avg.) $1.86B$2.03B$2.20B$2.37B$2.53B$833.7M$450.5M$271.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $109.4M$112.0M$117.9M$219.4M$492.4M$877.7M
Short-term investments $35.2M$73.9M$171.6M$155.6M
Receivables $31.6M$29.4M$28.0M$29.1M$55.8M$64.3M
Inventory $72.7M$52.9M$49.6M$61.4M$109.2M$94.5M
Total current assets $319.5M$321.6M$415.7M$508.7M$714.9M$1.09B
Property, plant and equipment $11.0M$10.2M$9.1M$11.0M$38.5M$43.7M
Goodwill $22.2M$21.2M$78.4M$124.3M$136.4M$3.2M
Other intangibles $76.9M$76.7M$94.6M$100.0M$117.0M$29.0M
Total assets $550.1M$544.0M$705.1M$850.0M$1.14B$1.27B
Accounts payable $9.9M$14.9M$17.4M$37.8M$71.5M
Total current liabilities $88.0M$87.7M$86.1M$85.3M$137.7M$173.3M
Total liabilities $121.0M$118.9M$115.7M$116.0M$198.4M$221.3M
Retained earnings -$1.16B-$1.10B-$1.03B-$957.0M-$907.3M-$649.8M
Total equity $430.5M$418.6M$582.4M$684.3M$888.1M$1.05B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow -$13.5M-$33.4M-$15.1M$19.7M-$160.1M-$150.7M
Depreciation and amortisation $5.3M$5.2M$7.6M$16.5M$20.5M$11.4M
Capital expenditure $6.0M$7.2M$6.1M$7.4M$22.2M$34.6M
Investing cash flow $35.3M$81.1M-$36.7M-$167.5M-$232.9M-$78.0M
Financing cash flow -$21.7M-$54.0M-$48.2M-$94.9M-$267.0K$1.02B
Buybacks $15.9M$55.6M$30.0M$94.9M$2.4M$75.3M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-192038.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $37.63B 207.7x 5.0%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
ELF e.l.f. Beauty, Inc. $6.47B 249.2x 24.6%
IPAR INTERPARFUMS INC $3.74B 22.3x 2.5%
COTY COTY INC. $2.58B -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.33B 54.5x -1.3%
WALD Waldencast plc $156.3M -0.7%